[The financing and price regulation of drugs in the Spanish National Health System: changes and continuity].
Puig-Junoy
Jaume
J
D017277:Drug Approval / Q000191:economics; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D004341:Drug Evaluation / Q000191:economics; D004353:Drug Evaluation, Preclinical / Q000191:economics; D004345:Drug Industry / Q000191:economics; D016568:Drugs, Generic / Q000191:economics; D005062:European Union; D005380:Financing, Government / Q000331:legislation & jurisprudence; D007880:Legislation, Drug / Q000191:economics*; D009313:National Health Programs / Q000191:economics* / Q000331:legislation & jurisprudence; D012109:Research Support as Topic / Q000331:legislation & jurisprudence; D013030:Spain
D016568:Drugs, Generic